Evaluation of the efficacy and safety of orally administered BI425809 during a 12‐week treatment period compared with placebo in patients with cognitive impairment due to Alzheimer’s disease
| Autor: | Frank Jessen, Stephane Pollentier, Miguel Garcia, Songqiao Huang, Glen Wunderlich, Zuzana Blahova |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Epidemiology business.industry Health Policy Disease Placebo Treatment period Psychiatry and Mental health Cellular and Molecular Neuroscience Developmental Neuroscience Internal medicine Medicine In patient Neurology (clinical) Geriatrics and Gerontology business Cognitive impairment |
| Zdroj: | Alzheimer's & Dementia. 16 |
| ISSN: | 1552-5279 1552-5260 |
| DOI: | 10.1002/alz.044797 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|